BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29773657)

  • 1. Review of the role of NICE in promoting the adoption of innovative cardiac technologies.
    Groves PH; Pomfrett C; Marlow M
    Heart; 2018 Nov; 104(22):1817-1822. PubMed ID: 29773657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of the UK National Institute of Health and Care Excellence evidence-based clinical guidelines on motor neurone disease.
    Oliver D; Radunovic A; Allen A; McDermott C
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):313-323. PubMed ID: 28513234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality, innovation, and value for money: NICE and the British National Health Service.
    Pearson SD; Rawlins MD
    JAMA; 2005 Nov; 294(20):2618-22. PubMed ID: 16304076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data briefing. NICE (National Institute for Clinical Excellence).
    Appleby J
    Health Serv J; 2000 Jun; 110(5708):32. PubMed ID: 11183800
    [No Abstract]   [Full Text] [Related]  

  • 5. A NEW HEALTH TECHNOLOGY ASSESSMENT SYSTEM FOR DEVICES: THE FIRST FIVE YEARS.
    Campbell B; Dobson L; Higgins J; Dillon B; Marlow M; Pomfrett C
    Int J Technol Assess Health Care; 2017 Jan; 33(1):19-24. PubMed ID: 28502278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the implementation of NICE guidance: cross-sectional survey of the use of NICE interventional procedures guidance by NHS Trusts.
    Lowson K; Jenks M; Filby A; Carr L; Campbell B; Powell J
    Implement Sci; 2015 Jun; 10():93. PubMed ID: 26122560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of the appraisal function of the National Institute for Clinical Excellence (NICE).
    Buxton M
    Value Health; 2001; 4(3):212-6. PubMed ID: 11705183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The future of the National Institute for health and Clinical Excellence].
    Assist Inferm Ric; 2013; 32(3):147-9. PubMed ID: 24158029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-informed evidence-making.
    Chalkidou K; Walley T; Culyer A; Littlejohns P; Hoy A
    J Health Serv Res Policy; 2008 Jul; 13(3):167-73. PubMed ID: 18573766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NICE work--providing guidance to the British National Health Service.
    Rawlins MD
    N Engl J Med; 2004 Sep; 351(14):1383-5. PubMed ID: 15459297
    [No Abstract]   [Full Text] [Related]  

  • 11. ASSESSING THE VALUE OF INNOVATIVE MEDICAL DEVICES AND DIAGNOSTICS: THE IMPORTANCE OF CLEAR AND RELEVANT CLAIMS OF BENEFIT.
    Campbell B; Campbell M; Dobson L; Higgins J; Dillon B; Marlow M; Pomfrett CJD
    Int J Technol Assess Health Care; 2018 Jan; 34(4):419-424. PubMed ID: 30025548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunity costs and local health service spending decisions: a qualitative study from Wales.
    Karlsberg Schaffer S; Sussex J; Hughes D; Devlin N
    BMC Health Serv Res; 2016 Mar; 16():103. PubMed ID: 27012523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adopting medical technologies and diagnostics recommended by NICE: the Health Technologies Adoption Programme.
    Chisholm S
    Ann R Coll Surg Engl; 2014 Jul; 96(5):400-1. PubMed ID: 24992441
    [No Abstract]   [Full Text] [Related]  

  • 14. When does NICE recommend the use of health technologies within a programme of evidence development? : a systematic review of NICE guidance.
    Longworth L; Youn J; Bojke L; Palmer S; Griffin S; Spackman E; Claxton K
    Pharmacoeconomics; 2013 Feb; 31(2):137-49. PubMed ID: 23329429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cancer technology appraisal programme of the UK's National Institute for Clinical Excellence.
    Littlejohns P; Barnett D; Longson C;
    Lancet Oncol; 2003 Apr; 4(4):242-50. PubMed ID: 12681268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NICE reports. NICE to see you...
    Bosanquet N
    Health Serv J; 2003 Jun; 113(5860):30-1. PubMed ID: 12852103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of Economic Submissions to NICE Medical Technologies Evaluation Programme.
    Alshreef A; Jenks M; Green W; Dixon S
    Appl Health Econ Health Policy; 2016 Dec; 14(6):623-634. PubMed ID: 27480537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact?
    Cowles E; Marsden G; Cole A; Devlin N
    Appl Health Econ Health Policy; 2017 Aug; 15(4):469-477. PubMed ID: 28130691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NICE process for developing quality standards and indicators.
    Bennett B; Coventry E; Greenway N; Minchin M
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(8-9):481-6. PubMed ID: 25523846
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.